Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|October 1, 1992
Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patientsG D Morse, A C Portmore, V Marder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1995
Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1L M Frenkel, L E Wagner, L M Demeter, et al.
The American Journal of Medicine|May 1, 1994
Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital wartsW Bonnez, R K Elswick, A Bailey-Farchione, et al.
Journal of Virology|August 23, 2000
Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell cultureR H Archer, C Dykes, P Gerondelis, et al.
Genes & Development|July 1, 1992
Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFFS C Dollard, J L Wilson, L M Demeter, et al.
Annals of Internal Medicine|May 1, 1988
Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trialR C Reichman, D Oakes, W Bonnez, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdineL M Demeter, P M Meehan, G Morse, et al.
Archives of Dermatology|March 1, 1986
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantarisJ C Vance, B J Bart, R C Hansen, et al.
The American Journal of Medicine|August 29, 1988
Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpesH R Mattison, R C Reichman, J Benedetti, et al.
The Journal of Infectious Diseases|February 1, 1983
Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trialR C Reichman, G J Badger, M E Guinan, et al.
Pageof 8